Combination therapy with fibrates and ursodeoxycholic acid improves biochemical markers in primary biliary cholangitis patients across multiple studies
Combination therapy improves biochemical markers in primary biliary cholangitis
An umbrella meta-analysis of meta-analyses involving 3,276 patients shows that adding fibrates to ursodeoxycholic acid significantly lowers …
Combining fibrates with ursodeoxycholic acid improves liver markers in primary biliary cholangitis patients, though survival data remain unc…
Review of triglyceride-lowering therapies for metabolic dysfunction-associated steatotic liver disease
New Hope for Fatty Liver Disease Targets Hidden Triglyceride Problem
This narrative review synthesizes evidence on triglyceride-lowering therapies for metabolic dysfunction-associated steatotic liver disease. …
• Lowering triglycerides may directly heal fatty liver damage • Helps millions with metabolic syndrome and stubborn liver fat • Most treatme…